Both in Pharmaceuticals
AEON Biopharma vs Lipocine
Over the past year AEON returned −76.2% and LPCN returned −45.1%; their daily moves had a correlation of 0.11.
AEON −76.2% LPCN −45.1%Growth of $1, one year, split-adjusted
| Metric | AEON | LPCN |
|---|---|---|
| Price | $0.2165 | $1.46 |
| Market cap | $12.8M | $12.0M |
| Today | +2.03% | −0.34% |
| 1 month | −25.3% | −30.7% |
| 6 months | −76.1% | −40.1% |
| Year to date | −80.3% | −81.9% |
| 1 year | −76.2% | −45.1% |
| Revenue growth (YoY) | — | −100.0% |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | 9.5× |
| Net cash | $743.0K | $23.3M |
| Dividend yield | — | — |
| Volatility (60d) | 127.9% | 57.5% |
| Short % of float | 28.5% | 4.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).